Fig. 3.

MWM measures of memory improve, and postsynaptic protein levels increase with AVAS treatment. a Open field (OFT) measure of total distance covered and % time in the periphery. b MWM acquisition/learning latency by training day c probe/memory trial latencies to target platform (left) and to target quadrant (right). d Western blot (top) for synaptic protein levels in the CX normalized to β-actin for quantification of PSD95 (left) and drebrin (right). Data are expressed as mean ± SEM (n = 10), analyzed by Student’s t test, p < 0.05, ✝= vs. VC